Preclinical Research on Cinnamic Acid Derivatives for the Prevention of Liver Damage: Promising Therapies for Liver Diseases
Authors:
Open Access
- 30 April 2025
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 13 (5)
Abstract
Background: Liver diseases are a global health issue with an annual mortality of 80,000 patients, mainly due to complications that arise during disease progression, as effective treatments are lacking. Objectives: This study evaluated the hepatoprotective effects of two derivatives of cinnamic acid, LQM717 and LQM755, in a murine model of acute liver damage induced by carbon tetrachloride (CCl4, 4 g/kg, single dose p.o.). Methods: Male Wistar rats were pretreated with five doses of LQM717 (20 mg/kg i.p.) or LQM755 (equimolar dose), starting 2 days before inducing hepatotoxic damage with CCl4. Results: The key parameters of hepatocellular function and damage showed significant increases in ALT, ALP, GGT, and total and direct bilirubin in rats intoxicated with CCl4, with decreased liver glycogen and serum albumin. Macroscopic and microscopic liver examinations revealed reduced inflammation, necrosis, and steatosis in animals pretreated with LQM717 or LQM755. Hepatomegaly was observed only in the LQM717 + CCl4 group. LQM755 statistically provided partial protection against increases in ALT and ALP and completely prevented elevations in GGT and total and direct bilirubin. LQM755 completely prevented albumin reduction, while LQM717 only partially prevented it. Both compounds partially prevented glycogen depletion. Bioinformatic analysis identified 32 potential liver protein targets for LQM717 and 36 for LQM755. Conclusions: These findings suggest that LQM717 and LQM755 have significant hepatoprotective effects against CCl4-induced acute liver injury, providing information for future studies in other acute and chronic models, as well as to elucidate their mechanisms of action.Keywords
Funding Information
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación (320331, CF-2023-I-195, 321878, IN206023, CI2406)
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación (320331, CF-2023-I-195, 321878, IN206023, CI2406)
- PAPIIT Program UNAM Project (320331, CF-2023-I-195, 321878, IN206023, CI2406)
- PIAPI FESC-UNAM (320331, CF-2023-I-195, 321878, IN206023, CI2406)
This publication has 57 references indexed in Scilit:
- SwissTargetPrediction: a web server for target prediction of bioactive small moleculesNucleic Acids Research, 2014
- The role of CYP3A4 in the biotransformation of bile acids and therapeutic implication for cholestasis2014
- The effect of caffeic acid phenethyl ester analogues in a modified resistant hepatocyte modelAnti-Cancer Drugs, 2013
- Protective effects of allopurinol against acute liver damage and cirrhosis induced by carbon tetrachloride: Modulation of NF-κB, cytokine production and oxidative stressBiochimica et Biophysica Acta (BBA) - General Subjects, 2012
- ChEMBL: a large-scale bioactivity database for drug discoveryNucleic Acids Research, 2011
- Antiviral therapy in HCV-infected decompensated cirrhoticsSaudi Journal of Gastroenterology, 2010
- Pharmacogenomics of Fluorouracil, Irinotecan, and Oxaliplatin in Hepatic Metastases of Colorectal CancerAmerican Journal of PharmacoGenomics, 2005
- Structure–hepatoprotective activity relationship of 3,4‐dihydroxycinnamic acid (caffeic acid) derivativesJournal of Applied Toxicology, 2001
- A Colorimetric Method for the Determination of Serum Glutamic Oxalacetic and Glutamic Pyruvic TransaminasesAmerican Journal of Clinical Pathology, 1957
- THE ESTIMATION OF GLYCOGEN WITH THE ANTHRONE REAGENT1950